Ex Parte WilkesDownload PDFPatent Trial and Appeal BoardAug 23, 201612425118 (P.T.A.B. Aug. 23, 2016) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 12/425,118 04/16/2009 45738 7590 08/25/2016 SENNIGER POWERS LLP (MTC) 100 NORTH BROADWAY 17THFLOOR ST LOUIS, MO 63102 FIRST NAMED INVENTOR Richard S. Wilkes UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. MTC 56786.2 1899 EXAMINER ZILBERING, ASSAF ART UNIT PAPER NUMBER 1792 NOTIFICATION DATE DELIVERY MODE 08/25/2016 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address( es): uspatents@senniger.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte RICHARD S. WILKES Appeal 2015-001371 Application 12/425,118 Technology Center 1700 Before ADRIENE LEPIANE HANLON, CATHERINE Q. TIMM, and JAMES C. HOUSEL, Administrative Patent Judges. PERCURIAM. DECISION ON APPEAL 1 STATEMENT OF THE CASE Appellant2 filed an appeal under 35 U.S.C. § 134 from the Examiner's decision finally rejecting claims 1, 3, 9, 10, 15, 19, 23, 35, 63, and 64 under 35 U.S.C. § 103(a) as being unpatentable over the combination ofBosco 3 in 1 Our decision refers to the Specification filed Apr. 16, 2009 (Spec.), Appellant's Appeal Brief filed Feb. 19, 2014 (Br.), the Examiner's Answer mailed Sept. 2, 2014 (Ans.), and Appellant's Reply Brief filed Nov. 3, 2014 (Reply Br.). 2 Appellant identified the real party in interest as Monsanto Technology LLC. Br. 2. 3 Bosco et al., US 4,273,790, issued June 16, 1981 (Bosco). Appeal 2015-001371 Application 12/425, 118 view ofUrsin4 and rejecting claims 12 and 62 under 35 U.S.C. § 103(a) as being unpatentable over the combination of Bosco and Ursin and further in view ofKnowlton. 5 We have jurisdiction under 35 U.S.C. §§ 6(b) and 134(a). We AFFIRM. The claims on appeal are directed to spread formulations (see, e.g., claim 1 ). Appellant discloses that studies have shown some types of fats to improve body function in some ways. Spec. i-f 4. In particular, many in the food industry have focused on the incorporation of omega-3 fatty acids into the diet. Spec. i-f 5. Omega-3 fatty acids are long-chain polyunsaturated fatty acids, such as stearidonic acid (SDA), alpha-linolenic acid (ALA), eicosatetraenoic acid (ET A), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA). Spec. i-f 5. Although nutritionists have identified DHA and EPA as physiologically important, SDA has also been shown to have significant health benefits. Spec. i-f 5. Securing an appropriate supply of long-chain polyunsaturated fatty acids, however, is difficult and cost restrictive. Spec. i-f 6. For instance, omega-3 fatty acids can quickly oxidize, which leads to undesirable odors and flavors. Spec. i-f 7. To counter this, food processors either distribute oils of fatty acids in a frozen condition or encapsulate the oil. Spec. i-f 7. These measures, however, increase cost and processing time for the fatty acids. Spec. i-f 7. In view of this, Appellant discloses using a comparatively 4 Ursin et al., WO 2005/021761 Al, published March 10, 2005 (Ursin). 5 Knowlton, US 5,981,781 A, issued Nov. 9, 1999 (Knowlton). 2 Appeal 2015-001371 Application 12/425, 118 chemically stable omega-3 fatty acid, SDA, to provide a spread formulation having improved nutritional quality, shelf-life, and cost in comparison to conventional margarine spread formulations. Spec. i-fi-f l, 12. Independent claim 1 is illustrative of the subject matter on appeal. Claim 1 is reproduced from the Claims Appendix of the Appeal Brief: 1. A spread formulation comprising an oil phase and an aqueous phase, wherein the oil phase comprises an oil having at least 10% by weight stearidonic acid (SDA) and wherein the oil phase further comprises a partially hydrogenated oil having a solids fat index of from about 19% to about 25.5% at 50°F (10°C), from about 10.5% to about 15.5% at 70°F (21°C), and from about 0.5% to about 4.0% at 92°F (33°C). Br. 11 (Claims App'x). OPINION Rejection over Bosco and Ursin Claims 1, 3, 9, 10, 15, 19, 23, 35, 63, and 64 are rejected under 35 U.S.C. § 103(a) as being unpatentable over the combination of Bosco in view of Ursin. Appellant addresses the rejection of various claims under separate headings. We do the same. Claim 1 For claim 1, the dispositive issue on appeal is whether Appellant has shown reversible error in the Examiner's reason to combine Bosco and Ursin to provide a spread formulation comprising an oil phase including an oil having at least 10% by weight SDA and the oil phase further comprising a partially hydrogenated oil having the solids fat index recited in claim 1. 3 Appeal 2015-001371 Application 12/425, 118 The Examiner finds Bosco discloses a spread formulation that is a margarine. Ans. 3. The spread formulation comprises an oil phase including vegetable oils, such as soybean oil. Ans. 3. The spread further comprises unhydrogenated or partly hydrogenated oils having a solids fat index of from 0-35% at 50°F, from 0-25% at 70°F, and less than 8% at 92 °F. Ans. 3. The Examiner finds the ranges of solids fat index disclosed by Bosco overlap with those of claim 1 and therefore render the solids fat index ranges of claim 1 obvious. Ans. 3. The Examiner finds Bosco does not disclose an oil phase comprising an oil with the SDA content of claim 1. Ans. 3. The Examiner finds Ursin discloses transgenic soybeans including at least 10 wt% SDA. Ans. 4. Ursin discloses that oil derived from the soybeans can be used in food, such as margarine, to provide SDA to consumers in view of its health benefits. Ans. 4. The Examiner concludes it would have been obvious to substitute the soybean oil of Ursin for the soybean oil of Bosco to provide the health benefits associated with the soybeans ofUrsin. Ans. 4. The Examiner also concludes it would have been obvious to substitute the soybean oil of Ursin for the soybean oil of Bosco because it would have been a simple substitution of one known element for another to obtain predictable results. Ans. 4. Appellant contends the Examiner failed to provide a reason why "a person of ordinary skill in the art would have selected the cited prior art references from the 'scope and content of the prior art,"' stating that "[b]oth Graham v. John Deere and KSR v. Teleflex require that there be a reason for selecting the particular prior art reference from the universe of prior art available at the time the claimed invention was made." Br. 4. 4 Appeal 2015-001371 Application 12/425, 118 Appellant's argument is based on a misunderstanding of the law. The question of obviousness is resolved on the basis of underlying factual determinations including ( 1) the scope and content of the prior art, (2) any differences between the claimed subject matter and the prior art, (3) the level of skill in the art, and ( 4) where in evidence, so-called secondary considerations. Grahamv.JohnDeereCo.,383U.S.1, 17-18(1966). See also KSR, 550 U.S. 398, 407 (2007) ("While the sequence of these questions might be reordered in any particular case, the [Graham] factors continue to define the inquiry that controls."). When combining the teachings of references to establish obviousness, one must ask what the combined teachings of the references would have suggested to one of ordinary skill in the art. In re Young, 927 F.2d 588, 591 (Fed. Cir. 1991); In re Keller, 642 F.2d 413, 425 (CCPA 1981). The question is whether making the combination is more than the predictable use of prior art elements according to their established functions. KSR Int'! Co. v. Teleflex Inc., 550 U.S. 398, 417 (2007). An examiner can establish obviousness by providing a rational reason why one of ordinary skill in the art would have combined the known elements in the fashion required by the claim. Id., at 418. Here, the Examiner's rejection was made within the analytical framework set forth by the Supreme Court. There is no convincing argument that Bosco and Ursin fail to be within the scope and content of the prior art. As stated by the Examiner, Bosco discloses a margarine and Ursin discloses an ingredient that may be incorporated into margarine to provide health benefits to a user. Ans. 8. The Examiner also found a difference between the spread formulation of the claim and the spread formulation of 5 Appeal 2015-001371 Application 12/425, 118 Bosco, by determining Bosco does not disclose an oil phase comprising an oil with the SDA content of claim 1. The Examiner then provided a reason to include the soybean oil of Ursin in the spread formulation of Bosco by citing the health benefits disclosed by Ursin as well as noting that the change is the substitution of a known element (soybean oil) for another (soybean oil containing SDA) to obtain the predictable result of forming margarine including the properties of the SD A-containing soybean oil. Ans. 4. Appellant argues the Examiner engaged in impermissible hindsight by relying upon insight provided by Appellants' disclosure. Br. 4--5. This is also unpersuasive of reversible error because Ursin discloses its soybean oil containing SDA provides "improved nutrition and health benefits." Ursin p. 10. Therefore, the Examiner's reason to combine flows from the knowledge that was within the level of ordinary skill at the time the claimed invention was made. Any judgment on obviousness is in a sense necessarily a reconstruction based upon hindsight reasoning, but so long as it takes into account only knowledge which was within the level of ordinary skill at the time the claimed invention was made and does not include knowledge gleaned only from applicant's disclosure, such a reconstruction is proper. In re McLaughlin, 443 F.2d 1392, 1395 (CCPA 1971). Appellant also traverses the Examiner's reason to substitute the soybean oil of Ursin for the soybean oil of Bosco because it would have been a simple substitution of one known element for another to obtain predictable results. First, Appellant contends the substitution would not have resulted in the spread formulation of claim 1 because Example VI of Bosco only includes the soybean oil and does not contain the partially hydrogenated oil of claim 1. Br. 5---6. This argument is not persuasive 6 Appeal 2015-001371 Application 12/425, 118 because, as stated by the Examiner at pages 10-11 of the Answer, examples and preferred embodiments do not constitute a teaching away from a broader disclosure. 6 Here, the Examiner finds Bosco discloses a spread formulation including a soybean oil and further including unhydrogenated or partly hydrogenated oils having a solids fat index of from 0-35% at 50°F, from 0- 25% at 70°F, and less than 8% at 92°F. Ans. 3. The disclosure of Bosco supports the Examiner's finding. Bosco col. 3, 11. 3-25. Appellant further contends that the results of substituting Ursin's soybean oil for the soybean oil of Bosco would not have been predictable. Br. 6. In particular, Appellant argues the results would have been unpredictable because the oxidative properties of soybean oils having a high SDA content can greatly vary, it was unpredictable whether the soybean oil of Ursin would have provided the appropriate stability and flavor profile for the spread formulation of Bosco, the solids fat indices ofUrsin and Bosco are very different so there would not have been a reasonable expectation of an acceptable spread, and a fat having a high solids fat index would have been needed to provide an appropriate consistency for a margarine formulation. Br. 6-7. Appellant's arguments are not persuasive of reversible error because they are mere attorney argument. See In re Pearson, 494 F.2d 1399, 1405 (CCPA 1974) ("Attorney's argument in a brief cannot take the place of evidence."). Appellant provides no convincing evidence or technical reasoning to demonstrate why the properties would have been so 6 Disclosed examples and preferred embodiments do not constitute a teaching away from a broader disclosure or non-preferred embodiments. In re Susi, 440 F.2d 442, 446 n.3 (CCPA 1971). 7 Appeal 2015-001371 Application 12/425, 118 unpredictable that an ordinary artisan would not have been capable of formulating a spread formulation as suggested by the references with a reasonable expectation of success. "For obviousness under § 103, all that is required is a reasonable expectation of success." In re 0 'Farrell, 853 F.2d 894, 903---04 (Fed. Cir. 1988) (citations omitted). In addition, Appellant asserts the spread formulation of claim 1 provides unexpected results. Br. 7. According to Appellant, "the spread formulation of claim 1 unexpectedly showed that its off flavor sensory score at 9 months was significantly similar to the spread formulation containing the control oil as compared to the spread formulations containing other omega-3 oils." Id. Appellant's showing fails because Appellant does not cite to any evidence to support this assertion of unexpected results. Id. See In re Heyna, 360 F.2d 222, 228 (CCPA 1966)("It is incumbent upon appellants to submit clear and convincing evidence to support their allegation of unexpected property"). In view of the above, Appellant has not identified a reversible error in the Examiner's reason to combine Bosco and Ursin to provide the spread formulation of claim 1. Nor has Appellant provided the type of evidence required to show that the spread formulation of the claim provides a result that would have been unexpected to those of ordinary skill in the art. Claims 19, 35, 62, and 64 Appellant also traverses the rejection of claims 19, 35, 62, and 64, focusing on the rejection of claim 19. Br. 7-8. We select claim 19 as representative. Claims 35, 62, and 64 stand or fall with claim 19. Claim 19 recites "[ t ]he spread formulation of claim 1 comprising a margarine formulation." Claim 19 (emphasis added). Although, as asserted 8 Appeal 2015-001371 Application 12/425, 118 by Appellant, 7 the Specification defines a "margarine spread formulation" as "an oil-in-water emulsion including about 80% (by weight) fat," 8 as pointed out by the Examiner, 9 "comprising" is not equal to "is." As determined by the Examiner, the claim is open to a mixture of a margarine formulation and other substances. Ans. 15-16. This determination is not disputed by Appellant. Reply Br. 4. Appellant contends one would not have looked to the disclosure of Bosco for guidance to prepare a margarine spread formulation of claim 19 because Bosco discloses a low fat liquid spread formulation having 5 to 40 weight percent fat. Br. 7. But as explained above, claim 19 is not limited to a higher fat composition. Thus, Appellant's argument is not convincing. For the reasons discussed above and those set forth in the Examiner's Answer, we sustain the Examiner's§ 103(a) rejection of claims 1, 3, 9, 10, 15, 19, 23, 35, 63, and 64 over the combination of Bosco and Ursin. Rejection over Bosco, Ursin, and Knowlton Claims 12 and 62 are rejected under 35 U.S.C. § 103(a) as being unpatentable over the combination of Bosco and Ursin and further in view of Knowlton. Claim 12 is representative of the issues on appeal for claims 12 and 62. Claim 12 depends from claim 1 and further recites "wherein the oil phase further comprises at least one high stability oil selected from the group consisting of low linolenic soybean oil, high oleic soybean oil, high 7 Appeal Br. 7. 8 Spec. ,-r 24. 9 Ans. 15-16. 9 Appeal 2015-001371 Application 12/425, 118 oleic/low saturate soybean oil, high oleic canola oil, and combinations thereof." In the rejection of claim 12, the Examiner finds Bosco does not disclose a high oleic soybean oil. Ans. 6. The Examiner finds Knowlton discloses high oleic soybean oils that can be mixed into oil products, such as margarines, to improve their characteristics, such as fatty acid composition, flavor, and/or oxidative stability. Ans. 6. The Examiner concludes it would have been obvious to modify the spread formulation of Bosco to include the high oleic soybean oil of Knowlton to improve the fatty acid composition, flavor, and/or oxidative stability of the spread formulation. Ans. 6. Appellant argues Knowlton does not remedy the deficiencies discussed above for Bosco and Ursin. Br. 8. As discussed above, we find no reversible error in the combination of Bosco and Ursin to remedy. Appellant further contends there would have been no reason to combine the high oleic soybean oil of Knowlton with Bosco and Ursin because Bosco and Ursin do not contemplate the oxidative stability of oil or a spread formulation. Br. 8. Appellant's argument is not persuasive of reversible error. As stated by the Examiner at page 16 of the Answer, the disclosure of Knowlton provides a reason to modify Bosco and Ursin. We further agree with the Examiner that there is no need for a primary reference to provide a reason to modify it in view of a secondary reference. Ans. 16. We further note the disclosure of Bosco considers oxidative stability by disclosing the use of antioxidants for resistance to oxidative deterioration at higher temperatures. Bosco col. 6, 11. 3-22. 10 Appeal 2015-001371 Application 12/425, 118 For the reasons discussed above and those set forth in the Examiner's Answer, we sustain the Examiner's§ 103(a) rejection of claims 12 and 62 over the combination of Bosco, Ursin, and Knowlton. DECISION The decision of the Examiner rejecting claims 1, 3, 9, 10, 12, 15, 19, 23, 35, and 62-64 under 35 U.S.C. § 103(a) is affirmed. No time period for taking any subsequent action in connection with this appeal maybe extended under 37 C.F.R. § 1.136(a)(l). AFFIRMED 11 Copy with citationCopy as parenthetical citation